Home ›
Entities
› academia
› BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies
Summary
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies is a scholarly article[1].
Key Facts
BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies's instance of is recorded as scholarly article[2].
References
Programmatic citations — every numbered marker resolves to a verifiable graph row below.
Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.
APA4ort.xyz Knowledge Graph. (2026). BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies. Retrieved May 24, 2026, from https://4ort.xyz/entity/boin12-bayesian-optimal-interval-phase-i-ii-trial-design-for-utility-based-dose-finding-in-immunotherapy-and-targeted-th
MLA“BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/boin12-bayesian-optimal-interval-phase-i-ii-trial-design-for-utility-based-dose-finding-in-immunotherapy-and-targeted-th.
BibTeX@misc{4ortxyz_boin12-bayesian-optimal-interval-phase-i-ii-trial-design-for-utility-based-dose-finding-in-immunotherapy-and-targeted-th_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies}}, year = {2026}, url = {https://4ort.xyz/entity/boin12-bayesian-optimal-interval-phase-i-ii-trial-design-for-utility-based-dose-finding-in-immunotherapy-and-targeted-th}, note = {Accessed: 2026-05-24}}
LLM promptAccording to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies — https://4ort.xyz/entity/boin12-bayesian-optimal-interval-phase-i-ii-trial-design-for-utility-based-dose-finding-in-immunotherapy-and-targeted-th (retrieved 2026-05-24)
